FORM 8-K

Company

IGC Pharma, Inc.

Filed

August 2, 2024

Period of Report

July 29, 2024

Accession Number

0001185185-24-000755

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →